TAK Pharmasp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-10-21
Share capital
50 000,00 PLN
Activity description

TAK Pharma is a Warsaw-based consultancy founded in 2004, specialising in pharmaceutical regulatory affairs. It supports pharmaceutical companies with regulatory affairs, pharmacovigilance, pricing and reimbursement, readability tests, medical translations and promotional material reviews, and advises on medical devices, food supplements and cosmetics.

Registered address
al. Wojska Polskiego 27/14, 01-515 Warszawa, Poland
Phone
Electronic delivery address
AE:PL-90493-45728-UCVVC-20

Financials

1 of the last 5 financial statements were filed late.

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.14mMedianUSD 164.14kAverageUSD 2.27m
Net profit
This companyUSD 247.94kMedianUSD 1.03kAverageUSD 108.21k
Operating costs
This companyUSD 348.59kMedianUSD 187.05kAverageUSD 2.07m
Assets
This companyUSD 2.26mMedianUSD 115.76kAverageUSD 1.52m

Bank accounts

Registered as a VAT taxpayer on 2004-11-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,004

Trademarks

TAK Pharma holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2005.

MarkProtected until
TAK Pharma Sp. z o.o.Jun 24, 2035

Authorized Representatives

Barbara Dobrzelewska Koczorowska – Vice President of the Management Board
Tomasz Andrzej Koczorowski – President of the Management Board
Barbara Dobrzelewska Koczorowska – Attorney-in-fact (joint)

Manner of representation

Each member of the management board acting independently is authorized to make declarations of will concerning the company's property rights and obligations and to sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
Tomasz Andrzej Koczorowski (63)
910$12,290.6591%
Others
90$1,215.569%

Beneficial owners

Person

Competitors

Name
Biofaktorsp. z o.o.
Noris Polskasp. z o.o.
2care4 Polandsp. z o.o.
PoltregS.A.
Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o.
Syntalpharmasp. z o.o.
Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o.
F1 PharmaS.A.
Ti-Comsp. z o.o.
Pexon Polandsp. z o.o.

Change history

DateEvent
2010-09-01PKD change
2004-10-21Entered in the register

FAQ

Last updated: 2026-07-16